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B I O C H E M I S T R Y
The human secretome
Mathias Uhlén1,2,3*, Max J. Karlsson1, Andreas Hober1, Anne-Sophie Svensson4, Julia Scheffel4, 
David Kotol1, Wen Zhong1, Abdellah Tebani1, Linnéa Strandberg1, Fredrik Edfors1,5, 
Evelina Sjöstedt3, Jan Mulder3, Adil Mardinoglu1, Anna Berling4, Siri Ekblad4, 
Melanie Dannemeyer4, Sara Kanje4, Johan Rockberg4, Magnus Lundqvist4, Magdalena Malm4, 
Anna-Luisa Volk4, Peter Nilsson1, Anna Månberg1, Tea Dodig-Crnkovic1, Elisa Pin1, 
Martin Zwahlen1, Per Oksvold1, Kalle von Feilitzen1, Ragna S. Häussler1, Mun-Gwan Hong1, 
Cecilia Lindskog6, Fredrik Ponten6, Borbala Katona6, Jimmy Vuu6, Emil Lindström6, Jens Nielsen7, 
Jonathan Robinson7, Burcu Ayoglu1, Diana Mahdessian1, Devin Sullivan1, Peter Thul1, 
Frida Danielsson1, Charlotte Stadler1, Emma Lundberg1, Göran Bergström8,9, 
Anders Gummesson8, Bjørn G. Voldborg2, Hanna Tegel4, Sophia Hober4, Björn Forsström1, 
Jochen M. Schwenk1, Linn Fagerberg1, Åsa Sivertsson1
The proteins secreted by human cells (collectively referred to as the secretome) are important not only for the 
basic understanding of human biology but also for the identification of potential targets for future diagnostics 
and therapies. Here, we present a comprehensive analysis of proteins predicted to be secreted in human cells, 
which provides information about their final localization in the human body, including the proteins actively 
secreted to peripheral blood. The analysis suggests that a large number of the proteins of the secretome are not 
secreted out of the cell, but instead are retained intracellularly, whereas another large group of proteins were 
identified that are predicted to be retained locally at the tissue of expression and not secreted into the blood. 
Proteins detected in the human blood by mass spectrometry–based proteomics and antibody-based immuno-
assays are also presented with estimates of their concentrations in the blood. The results are presented in an 
updated version 19 of the Human Protein Atlas in which each gene encoding a secretome protein is annotated to 
provide an open-access knowledge resource of the human secretome, including body-wide expression data, 
spatial localization data down to the single-cell and subcellular levels, and data about the presence of proteins 
that are detectable in the blood.
INTRODUCTION
An important class of human proteins are those that are actively 
transported within the secretory pathway for destinations outside 
the cytoplasm and nucleus of the cell. The collection of actively 
secreted proteins, herein referred to as the “human secretome,” 
constitutes a large fraction of the targets for pharmaceutical drugs, 
but these are also important as diagnostic targets both for classical 
clinical chemistry and as potential targets for future precision med-
icine efforts (1, 2). Many of these proteins are also involved in signal-
ing functions both locally and systemically, including proteins such 
as cytokines, growth factors, and hormones. Despite the huge interest 
in this class of proteins, there have been few attempts to define the 
size and constituents of the entire human secretome. A prediction 
of the number of putatively secreted proteins, defined as having a 
signal sequence and no transmembrane regions, was previously 
estimated to correspond to 2918 protein-coding genes, thus involving 
approximately 15% of all human genes (3). Attempts to characterize 
the proteins present in blood (the “plasma proteome”) have led to 
the development of multiplex assays involving thousands of protein 
targets using nucleic acid–based technologies (4, 5), immune-based 
assays (6), or mass spectrometry (MS) (7, 8). However, these plasma 
proteome efforts do not normally distinguish between actively 
secreted proteins (here defined as being part of the secretome) and 
proteins that are leaked by the millions of cells undergoing cell death 
at any given moment. In addition, many of the proteins secreted 
from human cells are not destined for the peripheral blood.
We therefore decided to stratify the actively secreted proteins in 
humans to define the spatial distribution of each protein with regard 
to its origin of expression and to provide a comprehensive list of 
annotated proteins based on their final localization in the body. 
Starting with a bioinformatics definition of the secretome, the pro-
teins were classified into three major categories: (i) the blood proteins, 
(ii) the locally secreted proteins, and (iii) the intracellular proteins. 
The latter might sound counterintuitive, but this category reflects the 
fact that many proteins secreted into the endoplasmic reticulum (ER) 
are sorted to various intracellular compartments, such as mitochondria 
and lysosomes, or they are even retained in the ER or Golgi. These 
proteins are thus not secreted out of the cell. The locally secreted 
proteins can further be classified into the various sublocalizations, 
such as the brain, as well as male and female tissues, and they also 
include proteins secreted to the digestive tract or those that end up 
in the extracellular matrix. Last, we annotated the proteins predicted 
to end up in peripheral blood, thus having important effects in the 
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human body, contributing to the systems-level control of homeostasis, 
transport of nutrients, inflammatory response, defense mechanisms, 
hormone regulation, and many other functions. To complement this 
annotation of the human secretome, we also investigated the pro-
teins found in blood using various technology platforms. All results 
are presented in a new version of the Human Protein Atlas (HPA) 
(www.proteinatlas.org/blood) with a “secretome” part including data 
on each gene encoding these proteins.
RESULTS
Revised list of the human secretome
We first performed a protein-centric transcriptomics scan to define 
a revised set of human secreted proteins (secretome) based on 
19,670 protein-coding genes predicted by Ensembl (9). For each 
protein-coding gene, all protein isoforms (splice variants) were 
annotated (Fig. 1A) on the basis of the presence of a signal peptide, 
transmembrane regions, or both, and each protein isoform was 
classified as being secreted, membrane bound, or intracellular. The 
secreted proteins are here defined according to the HPA classifica-
tion (3) as those proteins that have a signal peptide but lack a trans-
membrane region. The 338 Ensembl immunoglobulin genes (file S1) 
were excluded because of their complex genetic structure, which 
consists of many partial genes with variable (V), diversity (D), and 
joining (J) regions. In addition, proteins annotated as being secreted by 
UniProt (10) were added, which resulted in a list of 3513 genes with at 
least one predicted secreted isoform (transcript). From this list, pro-
teins with no corresponding entry in the current Ensembl version (v92) 
and genes for which the predicted secreted isoform has low evidence 
for existence were excluded. The revised number of genes encoding 
potentially secreted proteins (the human secretome) was 2641 (file S2). 
This list comprises approximately 13% of all human protein-coding 
genes, and it serves as a resource for all researchers interested in 
secreted proteins as targets for diagnostic and therapeutic drugs.
Annotation of the human secretome into localization classes
On the basis of the published literature, bioinformatics analysis, and 
experimental evidence, all genes coding for the putative secretome 
were subsequently manually annotated, taking into account their 
spatial distribution in the human body. Starting with a bioinformatics 
definition of the secretome, the proteins were classified into three 
major categories: (i) the blood proteins, (ii) the locally secreted pro-
teins, and (iii) the intracellular proteins. For the latter category, bio-
informatics evidence for intracellular locations was also used, such 
as ER retention signals (11), a peroxisome-targeting signal (12), and 
a mitochondrial target signal (13). The locally secreted proteins were 
further subdivided into seven classes to yield altogether nine protein 
categories (Fig. 1A). Note that the annotation considers the possible 
functional role of each protein and, as an example, the well-known 
plasma protein PSA (KLK3) was here annotated as being localized 
to male reproductive tissue and not the blood, because it was here 
assumed that the primary functional role of this protein is in the 
prostate. The annotation of all 2641 protein-coding genes identified 
730 proteins as blood secretome proteins, and about 500 were 
annotated as being secreted to local compartments, that is, male or 
female reproductive tissues, the brain, or other tissues, such as 
the eye or the skin. Eighty-eight proteins were identified as being 
secreted to the gastrointestinal tract, including 30 proteins produced 
in the pancreas and 25 in the salivary glands (fig. S1). More than 
200 proteins were further annotated to belong to the group of pro-
teins involved in the forming and function of the extracellular matrix, 
including both structural proteins, such as laminins, collagens, elastin, 
and fibronectin, and the matricellular proteins (14). More than 
900 proteins were annotated to be intracellular or membrane related, 
with 254 of these proteins predicted to be localized to the Golgi, ER, 
or both and 270 proteins being membrane associated. Last, about 
170 genes encoded proteins that lacked supporting data for their 
location. These are again interesting proteins for further studies to 
explore their function and location. A list of the genes in each cate-
gory was compiled (file S2) and is also available at the open-access 
Blood Atlas resource (www.proteinatlas.org/blood). Given that 
932 genes were annotated to encode intracellularly localized pro-
teins, despite having a predicted secreted isoform, the genome-wide 
annotation of the subcellular location of the protein-coding genes 
was revised (Fig. 1B). The resulting list of the human secretome 
consists of 1709 genes with at least one isoform (transcript) coding 
for a predicted secreted protein. Note that many genes encode mul-
tiple transcripts predicted to be in more than one location.
Functional analysis of those proteins predicted to be actively 
secreted to the blood
A functional analysis (Fig. 1C) of the 730 proteins predicted to 
be secreted to human blood revealed many well-characterized pro-
teins, such as cytokines, interleukins, interferons, and chemokines 
(altogether 154 proteins), complement and coagulation factors 
(n = 68 proteins), hormones (n = 75), growth factors (n = 33), and 
enzymes (n = 83). Many of these proteins are interesting pharma-
ceutical targets, and 72 are already the products or targets of U.S. 
Food and Drug Administration (FDA)–approved drugs (file S3) (15). 
Furthermore, almost 100 of the predicted secreted blood proteins have 
currently no functional annotation in UniProt; thus, these are interest-
ing targets for further exploration of their functional role in the blood.
The tissue distribution of the human secretome proteins
The tissue expression pattern of the human secretome genes was 
subsequently analyzed on the basis of transcriptomics data from the 
HPA. A classification according to tissue specificity as previously 
described (3) was performed for all of the secretome genes in the 
different annotation categories. The results showed that genes pre-
dicted to be locally expressed mainly consisted of tissue-enriched 
genes. Furthermore, genes encoding intracellular proteins generally 
showed low tissue specificity (Fig. 2A), which suggests that they have 
a more “house-keeping” role in the cell. Similarly, the matrix proteins 
are widely expressed across the analyzed tissues. A large portion of 
the blood proteins are produced in the liver, whereas others are gen-
erated either by blood cells or more generally across all tissues.
A cluster analysis (16) suggests that the expression profiles across 
the 730 blood proteins can be stratified into nine expression clusters 
(Fig. 2, B and C), and these can further be grouped according to 
tissue origin, including 139 proteins mainly originating from the 
liver (clusters A and D) with classical plasma proteins, such as albumin, 
transferrin, the apolipoproteins, and complement factors. Another 
group consists of the 174 proteins mainly originating from human 
blood cells, lymphoid tissues, or both (clusters C and F), which in-
clude many chemokines and granzymes. The 60 proteins that are 
mainly enriched in the brain (cluster E) constitute a third group 
to which several hormones and neuropeptides belong, including 
oxytocin, gonadotropin-releasing hormone, and pro-melanin 
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concentrating hormone. A fourth group includes 104 proteins with 
selective expression (cluster B), including interferons and hormones 
produced in specialized tissues, such as the placenta or endocrine 
glands. Last, there is a large group of 253 proteins that are expressed 
ubiquitously across many tissues (clusters G, H, and I). Many of 
these proteins are highly expressed in endothelial cells present 
throughout the body, which could explain their diverse expression, 
but it is also possible that some of the expression is related to the 
nonsecreted isoforms of the respective gene products and more in-
depth studies are needed to resolve the isoform-specific transcript 
abundances for these genes. The relationship between the clusters 
and protein functions are shown as a chord diagram (Fig. 2D), 
demonstrating that the genes in cluster B mainly encode cytokines 
and growth factors, whereas genes in cluster A encode not only 
complement, coagulation factors, and acute phase proteins but also 
transport proteins and enzymes.
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Fig. 1. Annotation of the human secretome. (A) Workflow used to predict the final location of components of the human secretome (n = 2641 proteins). The proteins 
are classified according to their predicted final location as seen in the pie chart (see file S2 for a complete list). (B) Predicted number of genes in the three indicated cate-
gories after considering the intracellular and membrane-bound annotations. (C) Functional analysis of the 730 proteins annotated as being blood proteins. The color code 
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Proteins detected in blood by MS
We subsequently decided to investigate the presence of the pre-
dicted secretome proteins in human blood based on MS and 
antibody-based immunoassays and to complement this with 
“in-house” analysis using a sensitive proximity extension assay (PEA) 
(17). For MS-based proteomics, protein concentrations in blood 
(Fig. 3A) were inferred by spectral counting (18) from a combined 
dataset of more than 170 publicly available experiments hosted in 
the Human Plasma PeptideAtlas (19). More than 3000 proteins 
were detected in this diverse set of experiments (file S4). The detected 
proteins were colored according to their predicted localization, 
with proteins annotated to be intracellular, membrane bound, or 
secreted and with the latter group stratified into those secreted to 
blood and those secreted to other compartments (according to 
Fig. 1). In this regard, note that there are a few abundant proteins 
that make up most of the protein mass in blood, with 99% of the 
protein mass corresponding to only a few proteins (20). However, 
many proteins are present at lower concentrations either resulting 
from active secretion or proteins leaked from cells due to normal 
cell turnover or pathology involving various diseases. The analysis 
showed that most of the proteins detected by MS were here defined 
as leakage proteins.
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Proteins detected in the blood by antibody-based 
immunoassays
We also compiled the plasma concentrations of proteins as detected 
by antibody-based immunoassays with a focus on the 730 proteins 
here defined as actively secreted to blood. A literature search was 
performed for each protein, and references were collected for those 
studies that reported the absolute concentrations in human plasma. 
In total, reference plasma or serum concentrations were found for 
365 of the 730 proteins secreted to the blood, and these values are 
presented on the Blood Atlas page of each gene and are combined 
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here for all of these proteins (Fig. 3B). The proteins are colored 
according to the functional annotation, and the results showed the 
expected high abundances for coagulation and complement factors, 
whereas cytokines, hormones, and growth factors often are present 
at low concentrations. Note that some of the actively secreted proteins 
with no annotated function were detected at relatively high concentra-
tions in the blood. A comparison of the concentrations for 205 proteins 
determined by both proteomics and immunoassays showed a good 
correlation with a Spearman’s  value of 0.79 (Fig. 3C).
Proteins detected in the blood by PEAs
Last, we analyzed blood samples from a healthy cohort with a mul-
tiplex PEA (17), covering 748 proteins involving both secreted and 
leakage products to investigate the longitudinal variability of these 
proteins during 1 year. As an example, the abundances of the pro-
tein leptin were measured for 86 individuals across 1 year and four 
consecutive visits with 3-month intervals (Fig. 3D). Although the 
average protein abundances are greater in females, the leptin con-
centrations of individuals were highly variable, with several males 
having consistently higher amounts during the assay period. These 
data support an individual-based definition of reference values for 
diagnostic applications and suggest that caution should be taken when 
using population-based data as a reference for health. The protein 
abundances across the individuals during 1 year for all 748 proteins 
analyzed are presented as part of the new Blood Atlas.
We subsequently assessed the detectability of each of the 2641 
secretome proteins based on the maximal transcript abundance in 
their respective tissue of origin (Fig. 3E). As expected, most of the 
proteins classified as blood proteins have been detected in blood, but 
it is also evident that many of the proteins classified in the other 
categories have been detected in blood, in particular many intracellular 
proteins and matrix proteins. The question arises as to whether this 
is due to these proteins having functional roles as circulating proteins 
or due to their leakage from the extracellular matrix. Furthermore, 
many of the proteins not detected by any assay were found to have 
low abundances in their predicted tissue of origin. On the basis of 
these three assay platforms, the overall detection of proteins secreted 
into the blood (n = 730) was summarized (Fig. 3F). Note that 142 of 
the blood secretome proteins were not detected (or lacked specific 
assays) across all three platforms, and none of the assay platforms 
was able to detect more than half of the blood secretome proteins. 
This finding demonstrates the importance of developing assays for 
this important group of blood proteins and highlights the need for 
systematic efforts to develop assays for the “missing proteins” by 
respective assay platform.
DISCUSSION
Here, we present an analysis of all of the proteins predicted to be 
secreted in humans based on sequence analysis of the corresponding 
transcripts, including all protein isoforms having a signal peptide 
and no transmembrane-spanning regions. We identified 2641 genes 
through this bioinformatics approach, and these genes were sub-
sequently annotated individually to reflect the destinations of their 
products in the human body. The annotation provides a view of the 
actively secreted proteins in humans; however, the quality of the 
annotation varies across the different proteins, mainly due to lack of 
experimental evidence, in particular limited information regarding 
genes with multiple transcript isoforms. The annotations of the 
individual proteins presented here will thus be revised when more 
information becomes available in the future. The results are pre-
sented in an updated version 19 of the HPA (www.proteinatlas.org/
blood) to provide an open-access knowledge resource of the human 
secretome.
Some conclusions can be made from the results presented here. 
First, note that the number of predicted actively secreted blood pro-
teins is surprisingly low (n = 730), corresponding to less than 4% of 
all human protein-coding genes. Among the proteins identified in 
this category of the secretome are not only the classical plasma pro-
teins, the inflammation proteins (cytokines and interleukins), well-
known hormones, and receptors but also close to 100 proteins with 
no annotated function yet. Similarly, 88 proteins were annotated to 
be secreted to the gastric tract, which again is a low number, but the 
list includes not only well-known digestive enzymes and defense 
proteins but also proteins that are much less studied. The analysis 
also revealed that the largest number of proteins was annotated to 
remain locally after secretion, including many matrix proteins 
(n = 234) and proteins that end up in specific tissues, including the 
brain and male and female tissues. However, the most unexpected 
finding from our analysis is that more than one-third (n = 932) of 
the proteins are predicted not to be secreted out of the cell. This 
intracellular category reflects the fact that many proteins are retained 
in the ER, Golgi, or both or are sorted to various intracellular com-
partments. More in-depth studies are needed to annotate the functions 
of many of these proteins.
The proteins detected in human blood were also analyzed, and 
the study resulted in an annotated list of proteins that have thus far 
been detected by MS-based proteomics and antibody-based immuno-
assays. The analysis revealed that for a large fraction of the secreted 
blood proteins, assays are lacking and a quest for the future is there-
fore to extend the respective assays to cover all the actively secreted 
proteins defined here, including relevant leakage proteins, to provide 
a secretome-wide toolbox of assays for the proteins in the blood to 
expand our capabilities for functional analysis and precision medicine 
efforts. In conclusion, the open-access resource presented here 
includes a genome-wide classification of all protein-coding genes 
with regard to the predicted spatial location in the human body of 
the corresponding proteins, as well as showing the cellular and/or 
tissue origin of each of the secretome proteins to facilitate basic and 
applied research involving this important class of proteins.
MATERIALS AND METHODS
Definition of the human secretome
The human secretome gene set includes Ensembl genes with either 
at least one splice variant encoding a protein with a signal peptide 
and no transmembrane regions according to HPA predictions (3) 
or for which UniProt has at least one isoform that is annotated as 
being secreted. From this gene set, the immunoglobulin-encoding 
genes were removed as were genes that encoded proteins for which 
there was little evidence of a secreted isoform.
Annotation of the human secretome
The genes were annotated into one of nine different categories 
based on the published literature, subcellular localization data from 
the HPA and UniProt, functional data from UniProt and HPA, 
RNA expression data from HPA, GTEx, and FANTOM, and protein 
expression data from HPA and UniProt. The annotation was 
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performed using an in-house annotation system displaying functional, 
expression, and subcellular location data from the different sources 
and links to relevant publications for each gene and the corresponding 
ensemble gene model with predicted signal peptides and trans-
membrane regions based on several algorithms (fig. S3). The anno-
tation was made on a gene level, and for genes that were found to 
have both secreted and intracellular or membrane-bound protein 
isoforms, only the secreted variant was annotated. For each gene, a 
single category was selected together with an explanatory comment 
and references to relevant articles. A short description and the hierarchy 
of the categories are shown in table S1.
Collection of protein plasma concentration  
references based on immunoassays
A literature search was performed for the 730 proteins annotated as 
being actively secreted to the blood, and the plasma concentrations 
of these proteins from up to three independent references were 
compiled. The search was limited to studies in which the protein 
concentrations had been determined using an antibody-based assay 
such as enzyme-linked immunosorbent assay, radioimmunoassay, 
or immunoturbidimetry. If reference concentrations from a mixed-
sex healthy control group could be found, then these values were 
used, but if no such values were available, then concentrations from 
condition-specific groups were accepted, for example, from pregnant 
women or different diseases. In some studies, the plasma concen-
trations were not explicitly stated and median concentrations had 
to be estimated from plots in the articles. The complete list of collected 
plasma protein concentrations and their corresponding reference 
articles can be found in file S5.
Retrieving MS-based plasma concentration  
data from the PeptideAtlas
For MS-based plasma proteomics, the data from >170 studies present 
in the PeptideAtlas (www.peptideatlas.org) were used. We queried 
for the “Human Plasma Non-Glyco 2017-04” build and set presence 
levels “canonical,” “no redundant relationships” for redundancy, 
and “show estimated abundances” as display options. This search 
revealed 3694 entries, from which the 22 labeled as contaminants 
(“CONTAM”) were removed. Of the remaining 3672 entries, 3484 
(93%) were listed with a protein concentration estimated by spectral 
counts column (“estimated_ng_per_ml”) (18). These data were sub-
sequently mapped to the ensemble gene set used in the HPA, and 
the 3223 remaining protein-coding genes were used in the analysis.
Plasma profiling using PEA
Plasma from 86 healthy individuals being part of the Swedish SCAPIS 
SciLifeLab Wellness Profiling (S3WP) (21) project was used for this 
analysis. The S3WP study is an observational study with the aim to 
collect longitudinal data in a community-based cohort, and the sub-
jects were recruited from the ongoing Swedish Cardio Pulmonary 
bioImage Study (SCAPIS) (22), which includes randomly selected 
subjects aged 50 to 65 years from the general Swedish population. 
Before sampling, all subjects fasted overnight, for at least 8 hours. 
Blood samples were drawn in EDTA tubes using standard operating 
procedures. All samples were stored at −80°C until used. Plasma 
proteins were analyzed using a multiplex PEA (Olink Bioscience, 
Uppsala, Sweden). Each kit provides a microtiter plate for measuring 
92 protein biomarkers in 90 samples (one panel), and in this study, 
11 panels were used, including Cardiometabolic, Cell Regulation, 
Cardiovascular II (CVD II), Cardiovascular III (CVD III), Development, 
Immune Response, Immuno-Oncology, Oncology II, Inflammation, 
Metabolism, Neurology, and Organ Damage. Each well in a kit con-
tains 96 pairs of DNA-labeled antibody probes. Samples were incu-
bated in the presence of proximity antibody pairs tagged with DNA 
reporter molecules. When the antibody pairs bind to their corre-
sponding antigens, the corresponding DNA tails form an amplicon 
by proximity extension, which can be quantified by high-throughput, 
real-time polymerase chain reaction (PCR). Briefly, 1 l of each 
sample was mixed with 3 l of probe solution containing a set of 92 
protein target–specific antibodies conjugated with distinctive DNA 
oligonucleotides. The mixture was incubated overnight at 4°C, and 
then 96 l of extension solution containing extension enzyme and 
PCR reagents was added. The generated fluorescent signal enabled 
the quantification of the protein using the BioMark HD System 
(Fluidigm Corporation). To minimize inter- and intra-run variation, 
the data were normalized using both an internal control (extension 
control) and an interplate control and were then transformed using a 
predetermined correction factor. The preprocessed data were provided 
in the arbitrary unit Normalized Protein eXpression (NPX) on a log2 
scale, which were then linearized by using the formula 2NPX. Thus, a 
high NPX value corresponds to a high protein concentration. The 
limit of detection for each protein was defined as three SDs above the 
background. A list of the 748 analyzed proteins can be found in file S6.
SUPPLEMENTARY MATERIALS
stke.sciencemag.org/cgi/content/full/12/609/eaaz0274/DC1
Fig. S1. Tissue of origin for proteins in different annotation categories.
Fig. S2. Expression profiles for the annotation categories.
Fig. S3. Some of the data displayed for the gene LALBA in the in-house annotation tool.
Table S1. Description of the annotation categories.
Data file S1. The immunoglobulin genes not annotated in this study.
Data file S2. The human secretome genes and their annotated categories.
Data file S3. Human blood secretome proteins that are targets for or act as FDA-approved 
pharmaceutical drugs according to DrugBank.
Data file S4. Proteins detected in blood by MS and their estimated concentrations.
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Data file S6. Proteins detected by PEAs in a longitudinal study of 86 healthy individuals.
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secreted proteins are retained locally rather than being released into the blood. These data serve as a resource for future 
suggests that many proteins that were thought to be secreted are retained intracellularly, and that another group of
analyses of the relative abundances, sites of origin, and final locations of proteins within the body. Their analysis 
based−that are predicted to be secreted and combined this with data derived from antibody- and mass spectrometry
 . analyzed the genes of the Human Protein Atlas that encode proteinset alreferred to as the human ''secretome.'' Uhlén 
collectivelypharmaceutical drugs, we lack a complete understanding of the size and composition of this group of proteins, 
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